The credit cycle can still bite. Royal Bank of Canada’s results were dented by one large corporate account — an unidentified ...

RBC Capital lowered the firm’s price target on PubMatic (PUBM) to $17 from $19 but keeps an Outperform rating on the shares. The company ...

Expecting buybacks to continue and adjusting his forecast to reflect the expectation for higher NII, offset by higher PCLs, Mr. Dechaine increased his target for RBC shares to $190 from $188, ...

The general mood among these heavyweight investors is divided, with 50% leaning bullish and 25% bearish. Among these notable ...

Canada's largest bank is bracing for the impact of a threatened U.S. 25% tariff on imports from north of the border. But the ...

The Royal Bank of Canada’s first-quarter earnings comfortably beat analysts’ expectations, but it was United States President ...

RBC reported a surge in impaired loans in its first quarter but says overall results were boosted by better-than-expected ...

The good, old Keystone XL pipeline is back in the news, after U.S. President Donald Trump told the world he wants it built ...

The Canadian central bank's decision to continue cutting rates in the reported quarter helped improve the environment for ...

These four blue-chip stocks are ideal for a TFSA: easy to set and forget for life or when you reach your next goal! The post ...

RBC Capital analyst Ben Hendrix lowered the firm’s price target on Select Medical (SEM) to $23 from $47 and keeps an Outperform rating on the ...